跳至主要内容
临床试验/NL-OMON23021
NL-OMON23021已完成不适用

A randomized controlled trial to assess the efficacy of a Food for Special Medical Purposes (FSMP) in patients with mild Alzheimer’s Disease.

Danone Research, Centre For Specialised Nutrition0 个研究点目标入组 226 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
226

研究概览

简要总结

Scheltens et al. J Alzheimers Dis. 2012 31(1):225-36.
De Waal et al. PLoS ONE. 2014 9(1): e86558.

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Diagnosis of probable AD according to the NINCDS-ADRDA criteria;
  • 2. MRI or CT scan within two years before baseline showing no evidence of any other potential cause of dementia other than AD;

排除标准

  • 1. Diagnosis of significant neurological disease other than AD;
  • 2. Use within 3 months prior to baseline, or expected need during the study of approved anti-AD medication;

研究者

发起方
Danone Research, Centre For Specialised Nutrition

相似试验

Souvenir II. | 临床试验